A Jj Pharma Corp (1140452) SEC Filing 8-K Material Event for the period ending Wednesday, May 9, 2007

SEC Filings

1140452 Corporate News

  • Accountant Change

    May 2007

A Jj Pharma Corp

CIK: 1140452

View differences made from one to another to evaluate A Jj Pharma Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by A Jj Pharma Corp.


Assess how A Jj Pharma Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

A Jj Pharma Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2007 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 1140452
Form Type: 8-K Corporate News
Accession Number: 0001199835-07-000329
Submitted to the SEC: Tue May 15 2007 8:18:11 PM EST
Accepted by the SEC: Wed May 16 2007
Period: Wednesday, May 9, 2007
Industry: Non Operating Establishments
  1. Accountant Change

External Resources:

Bookmark the Permalink: